Difficult-to-Treat Rejections in Kidney Transplant Recipients: Our Experience with Everolimus-Based Quadruple Maintenance Therapy

Difficult-to-Treat Rejections in Kidney Transplant Recipients: Our Experience with Everolimus-Based Quadruple Maintenance Therapy

All chronic and treatment-resistant acute rejections are “difficult-to-treat” and lead to progressive loss of graft function in kidney transplant recipients (KTR), as no effective treatment exists for such rejections to date. We review our experience with a novel strategy to treat such rejections by...

Full description

Bibliographic Details
Main Authors: Pierre Larsson, Bodil Englund, Jana Ekberg, Marie Felldin, Verena Broecker, Lars Mjörnstedt, Seema Baid-Agrawal
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Journal of Clinical Medicine
Subjects:
kidney transplantation
difficult-to-treat rejection
T cell-mediated rejection
chronic antibody-mediated rejection
quadruple therapy
everolimus
Online Access:https://www.mdpi.com/2077-0383/12/20/6667

Internet

https://www.mdpi.com/2077-0383/12/20/6667

Similar Items